Successful treatment of an NDM-5-producing, carbapenem-resistant Salmonella Kentucky ST198 infection with aztreonam and ceftazidime-avibactam in a patient with acute erythroid leukemia: a case report
Open Access
- 10 June 2026
- journal article
- case report
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Abstract
Introduction: Salmonella enterica serotype Kentucky ( S . Kentucky) is a globally distributed food-borne zoonotic pathogen. It is increasingly associated with multi-drug resistance (MDR), notably to ciprofloxacin, a trend largely attributed to antibiotic overuse in humans and livestock. Case presentation: An acute erythroid leukemia (AML-M6) man was found to be infected with carbapenem-resistant (CR) Salmonella enterica after chemotherapy. Salmonella serum agglutination test showed that the strain belonged to S . Kentucky. Antimicrobial susceptibility test showed that this strain is an MDR strain (resistant to carbapenems, ciprofloxacin, third-generation cephalosporins). Carbapenemase production was assessed via a colloidal gold immunochromatography assay and indicated expression of an NDM enzyme. Whole genome sequencing (WGS) revealed that this strain carried blaNDM-5, blaCTXM-55, and blaTEM-1 genes. Based on the identification of an NDM carbapenemase, in vitro synergy testing was performed, which demonstrated a synergistic effect between aztreonam and ceftazidime-avibactam. The patient was successfully treated with this combination regimen and recovered. Conclusions: This report describes an unusual infection caused by an NDM-5-producing S . Kentucky in an immunocompromised host. It underscores the necessity of employing combined phenotypic, immunologic, and molecular diagnostics to rapidly elucidate resistance mechanisms in such complex cases. Guided by this comprehensive analysis, the combination of aztreonam and ceftazidime-avibactam proved to be an effective, mechanism-based therapeutic strategy, highlighting its value in managing challenging infections in patients with hematological malignancies. Clinical trial number: Not applicable.Keywords
Funding Information
- Research Fund of Nanfang Hospital, Southern Medical University (2024B037)
- Research Fund of Nanfang Hospital, Southern Medical University (2021B03)
- Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0529005)
- Natural Science Foundation of Guangdong Province (2025A1515010067)
- Clinical Research project of Nanfang Hospital, Southern Medical University (2023CR015)
- Special Application for Research Project on Pathogenic Microorganism Detection Technology and Infection Prevention and Control (BH006531)
- National Key Research and Development Program of China (2022YFC2406400)
- Higher Education Teaching Reform Project (24NJ-YB08)
This publication has 22 references indexed in Scilit:
- Global genomic survey of Salmonella Kentucky: discovery of a chromosomeborne bla NDM-5 and the emergence of ST314, an MDR clone mediated by the IncR plasmidEmerging Microbes & Infections, 2025
- Emergence of ciprofloxacin- and tigecycline-resistant extended-spectrum β-lactamase (ESBL)-producing Salmonella enterica serovar Kentucky ST198 from horse, ChinaJournal of Global Antimicrobial Resistance, 2025
- A global atlas and drivers of antimicrobial resistance in Salmonella during 1900-2023Nature Communications, 2025
- IS15DIV-flanked composite transposon harboring blaNDM-5 in multidrug-resistant Salmonella TyphimuriumiScience, 2024
- Exploring the dynamics of gut microbiota, antibiotic resistance, and chemotherapy impact in acute leukemia patients: A comprehensive metagenomic analysisVirulence, 2024
- Genomic insights into a clinical Salmonella Typhimurium isolate carrying plasmid-mediated blaNDM-5Journal of Global Antimicrobial Resistance, 2024
- Diverse lineages of multidrug resistant clinical Salmonella enterica and a cryptic outbreak in New Hampshire, USA revealed from a year-long genomic surveillanceInfection, Genetics and Evolution, 2021
- Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing EnterobacteralesClinical Infectious Diseases, 2020
- Efficacy of ceftazidime/avibactam in monotherapy or combination therapy against carbapenem-resistant Gram-negative bacteria: A meta-analysisInternational Journal of Antimicrobial Agents, 2019
- Isolation and plasmid characterization of carbapenemase (IMP-4) producing Salmonella enterica Typhimurium from catsScientific Reports, 2016